PHAS - PhaseBio Pharmaceuticals EPS misses by $0.14 misses on revenue May, 13 2021 05:17 PM PhaseBio Pharmaceuticals Inc. PhaseBio Pharmaceuticals (PHAS): Q1 GAAP EPS of -$0.87 misses by $0.14.Revenue of $0M misses by $0.02M.Press Release For further details see: PhaseBio Pharmaceuticals EPS misses by $0.14, misses on revenue